Announced details
Nonclinical in vivo kinetics analysis of cell-based medicines, PK/PD analysis, and research and development of next-generation cell therapies
More accurate assessment of cell concentrations is expected, but figures such as the improvement rate are Not disclosed.
Helios will present its research findings at the society’s annual meeting.
The society holding the 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics. Other information is Not disclosed.
Tsukuba International Congress Center (presentation venue)
No information on the impact on financial results: Not disclosed.
The company does not address Contract Value / Offering price.
41st Annual Meeting of the Japanese Society for the Study of Xenobiotics in Tsukuba; the society’s website
| Item | Details |
|---|---|
| Names of Products / Services Covered | eNK® cells, AKT-01/HLCN061, Direct qPCR method |
| Counterparty | Japanese Society for the Study of Xenobiotics |
| Counterparty overview | The society holding the 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics. Other information is Not disclosed. |
| Relationship with the Company | Helios will present its research findings at the society’s annual meeting. |
| Launch date | 18 November 2026 (scheduled presentation) |
| Applicable area | Nonclinical in vivo kinetics analysis of cell-based medicines, PK/PD analysis, and research and development of next-generation cell therapies |
| Location | Tsukuba International Congress Center (presentation venue) |
| Quantitative Effects | More accurate assessment of cell concentrations is expected, but figures such as the improvement rate are Not disclosed. |
| Impact on Business Performance | No information on the impact on financial results: Not disclosed. |
| Source | 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics in Tsukuba; the society’s website |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The conventional method involved complicated procedures, and variability in DNA extraction efficiency affected the accuracy of cell-count evaluation. The company states that the Direct qPCR method simplifies the evaluation process and enables more accurate assessment of cell concentrations in organs and blood.